Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Measuring manufacturing growth afresh: Three questions

Measuring manufacturing growth afresh: Three questions

Three questions regarding Indian manufacturing performance have emerged as the country grapples with the implications of its manufacturing export expansion and government initiatives like Make in India and PLI schemes. First, the manufacturing Gross Value Added (GVA) price deflator has experienced negative growth for nine consecutive quarters, a puzzling trend that does not align with overall price deflation in the economy.

Second, there is a significant divergence between real GVA and the Index of Industrial Production (IIP) for manufacturing, with the former outpacing the latter by 15 percentage points in 2025-26. Third, the correlation between real GVA and IIP growth rates has weakened dramatically since 2011-12, contrasting with a strong 0.8 correlation before the 2011-12 methodology changes.

These questions are crucial in understanding the performance of India's manufacturing sector and its ability to withstand competition from China and the government's efforts to revitalize the industry.

Written by urgent.news from The Indian Express's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Read the original at indianexpress.com →

More in Finance & Markets

Can Symbiotec Pharmalab IPO deliver long-term growth for high-risk investors?

Symbiotec Pharmalab plans a ₹150 crore IPO to repay debt and expand operations. The company holds a global leadership position in corticosteroid and steroidal-hormone APIs.

  • Symbiotec Pharmalab raising ₹150 crore through IPO for debt repayment
  • Company specializes in APIs, nutritional ingredients, specialty products
  • Global leader in corticosteroid and steroidal-hormone APIs with 38.2% market share

More from Monday 24 August →